Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-047127
Filing Date
2023-08-23
Accepted
2023-08-23 19:58:17
Documents
1
Period of Report
2023-08-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4500
  Complete submission text file 0001209191-23-047127.txt   5876
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Issuer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEGO CA 92121
Business Address
ABERNETHY MATT (Reporting) CIK: 0001724097 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22705 | Film No.: 231198685